Skip to main content
SpringerLink
Log in

Pediatric Vasculitis

  • Chapter
A Clinician's Pearls and Myths in Rheumatology

Abstract

Based on surverys of providers, vasculitis in children appears to have an incidence of about 50 cases per 100,000 children per year. Only HSP and KD are more common in children than in adults, with each one affecting at least 10–20/100,000 pediatric patients per year. Takayasu arteritis and ANCA-positive vasculiti-des, on the other hand, strike approximately one child in a million each year. Differences between adult and pediatric vasculitides are generally subtle, though they may have important implications. Since these conditions are so rare in the pediatric age group, diagnosis may be significantly delayed, leading to more disease-related damage at the time therapy is initiated. In addition, unlike adults, children may suffer irreversible effects on their physical and mental development both from the disease and from the medications used to treat it. On the other hand, children tend to have fewer comor-bidities and they are therefore more tolerant of potentially toxic therapies. This often results in better outcomes for children than adults, especially in conditions like Takayasu arteritis and PAN. Kawasaki disease (KD) has replaced acute rheumatic fever as the leading cause of acquired heart disease among children in developed nations. Since IVIG became the standard treatment for KD in 1986, the mortality rate of the disease has decreased from 1–2% to <0.1%, and the incidence of coronary artery aneu-rysms has decreased by 75%. Henoch-Schonlein purpura, also known as anaphylac-tic purpura, is a benign condition in the vast majority of affected children. Nonetheless, in rare cases, children affected by HSP may develop hypertension (especially during pregnancy) or renal failure long after the acute syndrome has resolved. One-third or more of children with PAN have the cutaneous form, largely limited to skin and joint involvement. While mortality is rare, aggressive control of the systemic inflammation and end-organ involvement is nonetheless needed if significant long-term morbidity is to be avoided.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Allen AC, Willis FR, Beattie TJ, et al. Abnormal IgA glycosylation in Henoch–Schönlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant. 1998;13:930–4

    Article  PubMed  CAS  Google Scholar 

  • Amano S, Hazama F, Kubagawa H, et al. General pathology of Kawasaki disease. Acta Pathol Jpn. 1980;30(5):681–94

    PubMed  CAS  Google Scholar 

  • Anderson MS, Burns J, Treadwell TA, et al. Erythrocyte sedimentation rate and C-reactive protein discrepancy and high prevalence of coronary artery abnormalities in Kawasaki disease. Pediatr Infect Dis J. 2001;20(7):698–702

    Article  PubMed  CAS  Google Scholar 

  • Bártfai Z, Gaede KI, Russell KA, et al. Different gender-associated genotype risks of Wegener's granulomatosis and microscopic poly-angiitis. Clin Immunol. 2003;109(3):330–7

    Article  PubMed  Google Scholar 

  • Binstadt BA, Levine JC, Nigrovic PA, et al. Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic arthritis. Pediatrics 2005;116:e89–93

    Article  PubMed  Google Scholar 

  • Birchmore D, Sweeney C, Choudhury D, et al. IgA multiple myeloma presenting as HSP/Polyarteritis nodosa overlap. Arthritis Rheum. 1996;39:698–703

    Article  PubMed  CAS  Google Scholar 

  • Burns JC, Wiggins JW, Toews WH, et al. Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr. 1986;109:759–63

    Article  PubMed  CAS  Google Scholar 

  • Burns JC, Mason WH, Glode MP, et al. Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. J Pediatr. 1991;118:680–6

    Article  PubMed  CAS  Google Scholar 

  • Burns JC, Shimizu C, Shike H, et al. Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease. Genes Immun. 2005;6(5):438–44

    Article  PubMed  CAS  Google Scholar 

  • Cakar N, Yalcinkaya F, Duzova A, et al. Takayasu arteritis in children. J Rheumatol. 2008;35(5):913–19

    PubMed  Google Scholar 

  • Centers for Disease Control. Haemophilus influenzae invasive disease among children age <5 years–California, 1990–1996. MMWR. 1998;47:737–40

    Google Scholar 

  • Choong CK, Beasley SW. Intra-abdominal manifestations of Henoch-Schönlein purpura. J Paediatr Child Health. 1998;34:405–9

    Article  PubMed  CAS  Google Scholar 

  • Daoud MS, Hutton KP, Gibson LE. Cutaneous periarteritis nodosa: a clini-copathological study of 79 cases. Br J Dermatol. 1997;136:706–13

    Article  PubMed  CAS  Google Scholar 

  • Dengler LD, Capparelli E V, Bastian JF, et al. Cerebrospinal fluid profile in patients with acute Kawasaki disease. Pediatr Infect Dis J. 1998;17:478–81

    Article  PubMed  CAS  Google Scholar 

  • Frosch M, Foell D. Wegener granulomatosis in childhood and adolescence. Eur J Pediatr. 2004;163:425–34

    Article  PubMed  Google Scholar 

  • Golding RL, Perri G, Cremin BJ. The arteriographic manifestations of Takayasu's arteritis in children. Pediatr Radiol. 1977;5:224–30

    Article  PubMed  CAS  Google Scholar 

  • Goldstein AR, White RHR, Akuse R, et al Long-term follow-up of childhood Henoch-Schönlein nephritis. Lancet 1992;339:280–2

    Article  PubMed  CAS  Google Scholar 

  • Holman RC, Belay ED, Curns AT, et al. Kawasaki syndrome hospital-izations among children in the United States, 1988–1997. Pediatrics 2003;111:e448

    Article  Google Scholar 

  • Jurado RL. Why shouldn't we determine the erythrocyte sedimentation rate? Clin Infect Dis. 2001;33:548–9

    Article  PubMed  CAS  Google Scholar 

  • Kumar L, Thapa BR, Sarkar B, Walia BN. Benign cutaneous PAN in children below 10 years of age: a clinical experience. Ann Rheum Dis. 1995;54:134–6

    Article  PubMed  CAS  Google Scholar 

  • Landing BH, Larson EJ. Are infantile periarteritis nodosa with coronary artery involvement and fatal mucocutaneous lymph node syndrome the same? Comparison of 20 patients from North America with patients from Hawaii and Japan. Pediatrics 1977;59:651–62

    PubMed  CAS  Google Scholar 

  • Momenah T, Sanatani S, Potts J, et al. Kawasaki disease in the older child. Pediatrics 1998;e102(1):e7

    Article  Google Scholar 

  • Muta H, Ishii M, Sakaue T, et al Older age is a risk factor for the development of cardiovascular sequelae in Kawasaki disease. Pediatrics 2004;114:751–4

    Article  PubMed  Google Scholar 

  • Narchi H. Risk of long term renal impairment and duration of follow up recommended for Henoch–Schönlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child. 2005;90:916–20

    Article  PubMed  CAS  Google Scholar 

  • Newburger J, et al Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, Am Heart Assoc Pediatr. 2004a;114:1708–33

    Google Scholar 

  • Newburger JW, Sanders SP, Burns JC, et al Left ventricular contractility and function in Kawasaki syndrome. Circulation 1989;79:1237–46

    Article  PubMed  CAS  Google Scholar 

  • Newburger JW, Takahashi M, Gerber MA, et al Diagnosis, treatment, and long-term management of Kawasaki disease. Circulation 2004a;110:2747–71

    Article  Google Scholar 

  • Niwa K, Aotsuka H, Hamada H, et al. Thrombocytopenia: a risk factor for acute myocardial infarction during the acute phase of Kawasaki Disease. Coron Artery Dis. 1995;6(11):857–64

    PubMed  CAS  Google Scholar 

  • Ozdogan H, Arisoy N, Kasapcapur O, et al. Vasculitis in familial Mediterranean fever. J Rheumatol. 1997;24:323–7

    PubMed  CAS  Google Scholar 

  • Ozen S, Bakkaloglu A, Yilmaz E, Duzova A, Balci B, Topaloglu R, Besbas N. Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation? J Rheumatol. 2003;30(9):2014–8

    PubMed  CAS  Google Scholar 

  • Ozen S, Anton J, Arisoy N, et al. Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr. 2004;145:517–22

    Article  PubMed  Google Scholar 

  • Ozen S, Ruperto N, Dillon MJ, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65:936–41

    Article  PubMed  CAS  Google Scholar 

  • Ozen S, Duzova A, Bakkaloglu A, et al. Takayasu arteritis in children: preliminary experience with cyclophosphamide induction and corti-costeroids followed by methotrexate. J Pediatr. 2007;150:72–6

    Article  PubMed  CAS  Google Scholar 

  • Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch–Schönlein purpura: a retrospective cohort study. Lancet 2002;360:666–70

    Article  PubMed  Google Scholar 

  • Ronkainen J, Ala-Houhala M, Huttunen NP, et al. Outcome of Henoch-Schoenlein nephritis with nephrotic-range proteinuria. Clin Nephrol. 2003;60:80–4

    PubMed  CAS  Google Scholar 

  • Ronkainen J, Koskimies O, Ala-Houhala M, et al. Early prednisone therapy in Henoch-Schönlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr. 2006;149:241–7

    Article  PubMed  CAS  Google Scholar 

  • Rosenfeld EA, Corydon KE, Shulman ST. Kawasaki disease in infants less than one year of age. J Pediatr. 1995;126:524–49

    Article  PubMed  CAS  Google Scholar 

  • Rottem M, Fauci AS, Hallahan CW, et al. Wegener granulomatosis in children and adolescents: clinical presentation and outcome. J Pediatr. 1993;122(1):26–31

    Article  PubMed  CAS  Google Scholar 

  • Saulsbury FT. Corticosteroid therapy does not prevent nephritis in Henoch–Schönlein purpura. Pediatr Nephrol. 1993;7:69–71

    Article  PubMed  CAS  Google Scholar 

  • Saulsbury FT. Alterations in the O-linked glycosylation of IgA1 in children with Henoch-Schönlein purpura. J Rheumatol. 1997;24:2246–9

    PubMed  CAS  Google Scholar 

  • Saulsbury FT. Henoch-Schönlein purpura in children: report of 100 patients and review of the literature. Medicine 1999;78:395–409

    Article  PubMed  CAS  Google Scholar 

  • Saulsbury FT. Henoch-Schönlein purpura. Curr Opin Rheumatol. 2001;13:35–40

    Article  PubMed  CAS  Google Scholar 

  • Seo P, Luqmani R, Flossmann O, et al. The future damage assessment in vasculitis. J Rheumatol. 2007;34:1357–71

    PubMed  Google Scholar 

  • Spriewald BM, Witzke O, Wassmuth R, et al. Distinct tumour necrosis factor alpha, interferon gamma, interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener's granulomatosis. Ann Rheum Dis. 2005;64:457–61

    Article  PubMed  CAS  Google Scholar 

  • Stamos JK, Corydon K, Donaldson J, Shulman ST. Lymphadenitis as the dominant manifestation of Kawasaki disease. Pediatrics 1994;93(3):525–8

    PubMed  CAS  Google Scholar 

  • Stockheim JA, Innocentini N, Shulman ST. Kawasaki disease in older children and adolescents. J Pediatr. 2000;137:250–2

    Article  PubMed  CAS  Google Scholar 

  • Stone JH, Nousari HC. Essential cutaneous vasculitis: everything a rheumatologist needs to know about vasculitis of the skin. Curr Opin Rheumatol. 2001;13:23–34

    Article  PubMed  CAS  Google Scholar 

  • Tanaka N, Sekimoto K, Naoe S. Kawasaki disease. Relationship with infantile periarteritis nodosa. Arch Pathol Lab Med. 1976;100:81–6

    PubMed  CAS  Google Scholar 

  • Trapani S, Micheli A, Grisolia F, et al. Henoch-Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of the literature. Semin Arthritis Rheum. 2005;35:143–53

    Article  PubMed  Google Scholar 

  • Tse W Y, Cockwell P, Savage CO. Assessment of disease activity in systemic vasculitis. Postgrad Med J. 1998;74:1–6

    Article  PubMed  CAS  Google Scholar 

  • Umezawa T, Saji T, Matsuo N, Odagiri K. Chest X-ray findings in the acute phase of Kawasaki disease. Pediatr Radiol. 1989;20(1–2):48–51

    Article  PubMed  CAS  Google Scholar 

  • van Leeuwen MA, van Rijswijk MH. Acute phase proteins in the monitoring of inflammatory disorders. Baillieres Clin Rheumatol. 1994;8(3):531–52

    Article  PubMed  Google Scholar 

  • Wickiser JE, Saulsbury FT. Henoch-Schönlein purpura in a child with hyperimmunoglobulinemia D and periodic fever syndrome. Pediatr Dermatol. 2005;22:138–41

    Article  PubMed  Google Scholar 

  • Yalçinkaya F, Ozçakar ZB, Kasapçopur O, et al. Prevalence of the MEFV gene mutations in childhood PAN. J Pediatr. 2007;151:675–8

    Article  PubMed  Google Scholar 

  • Yanagawa H, Nakamura Y, Yashiro M, et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics 2001; 107(3):e33

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology/Immunology Ward 12-140, Pediatrics W-140, Northwestern University Medical School, Chicago, IL, 60611-3008, USA

    Anne H. Rowley

  2. Department of Pediatric Nephrology and Rheumatology, Hacettepe University Faculty of Medicine, Sihhiye, Ankara, 06100, Turkey

    Seza Ozen

  3. Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02115, USA

    Robert P. Sundel

  4. University of Virginia Medical Center Department of Pediatrics, 800386, Charlottesville, Virginia, 22908, USA

    Frank T. Saulsbury

Authors
  1. Anne H. Rowley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seza Ozen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert P. Sundel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Frank T. Saulsbury
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Clinical Rheumatology, Massachusetts General Hospital, 55 Fruit Street / Yawkey 2, Boston, MA, 02114

    John H. Stone (Director) (Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Rowley, A.H., Ozen, S., Sundel, R.P., Saulsbury, F.T. (2009). Pediatric Vasculitis. In: Stone, J.H. (eds) A Clinician's Pearls and Myths in Rheumatology. Springer, London. https://doi.org/10.1007/978-1-84800-934-9_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-84800-934-9_21

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84800-933-2

  • Online ISBN: 978-1-84800-934-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation